Poland· PL-100078915
Enterol
A antidiarrheal microorganisms product containing saccharomyces boulardii, registered in Poland by BIOCODEX. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Saccharomyces boulardii is registered in 4 of 19 countries.
Countries holding a registration under ATC A07FA (antidiarrheal microorganisms), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Saccharomyces boulardii · ATC A07FA
4 / 19 countries
- Finlandprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Saccharomyces boulardii
- Manufacturer
- BIOCODEX
- Country
- Poland (PL)
- ATC code
- A07FA
- ATC class
- Antidiarrheal microorganisms
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990748518
- gtin05909990748525
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saccharomyces boulardii in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEnterol 250 mgPI Pharma
- SpainULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORALPetsiavas S.A. Industrial And Commercial Enterprises
- CzechiaENTEROLBIOCODEX, Gentilly
- FinlandPrecosaBiocodex
- GermanyBoulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, LyophilisiertPharma Zentrale Gmbh
- United StatesA-34DNA Labs, Inc.
- United KingdomBiome Balance For those on Antibiotics 300mg capsulesLamberts Healthcare Ltd
- NorwayCodex 5 miliardiBiocodex
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Yomogi
- Belgium · Sacchiflora
- Cyprus · Bioflor
- Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
- Italy · Codex, Preparazione H
- Portugal · Prolif
- Sweden · Precosa
- Slovakia · Yomogi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/966330b4-5f4d-4072-b362-05c527e901cd GET /v1/drugs/966330b4-5f4d-4072-b362-05c527e901cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania zawiesiny doustnej",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909990748518 ¦ OTC ¦ 11843\n10 sasz. \n05909990748525 ¦ OTC ¦ 11844\n20 sasz.",
"substance": "Saccharomyces boulardii CNCM I-745 250 mg + Saccharomyces boulardii (liofilizowane drożdżaki) 250 mg",
"common_name": "Saccharomyces boulardii",
"pl_product_id": "100078915",
"pozwolenie_nr": "07485",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about saccharomyces boulardii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.